1.  Vos T et al Lancet. 2016;388(10053):1545–602
  2.  Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19(2):164–174.
  3.  Beard JL. Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning. J Nutr. 2001:568–580.
  4.  Piñero DJ, Connor JR. Iron in the Brain: An Important Contributor in Normal and Diseased States. Neurosci. 2000;6(6):435–453.
  5.  Radlowski EC Johnson RW Perinatal iron deficiency and neurocognitive development Front Hum Neurosci. 2013; 7: 585.
  6.  Jáuregui-lobera I. Iron deficiency and cognitive functions. Neuropsychiatr Dis Treat. 2014;10:2087–2095.
  7.  Butler J; An overview of chronic heart failure management. Nurs Times. 2012;108(14/15):16–20
  8.  What is Heart Failure? Abrufbar unter: www.heartfailurematters.org/en_GB/Understanding-heart-failure/What-is-heart-failure. Zuletzt abgerufen: 18. September 2019.
  9.  Bakogiannis, C., et al., Iron deficiency as therapeutic target in heart failure: a translational approach. Heart Fail Rev, 2019.
  10.  Stugiewicz, M., et al., The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications. Eur J Heart Fail, 2016. 18(7): S. 762–73
  11.  Wong CCY, Ng ACC, Kritharides L, Sindone A. Iron deficiency in heart failure: Looking beyond anaemia. Heart Lung Circ 2016; 25: 209–216
  12.  Drozd M, Jankowska EA, Waldemar Banasiak W, Ponikowski P. Iron therapy in patients with heart failure and iron deficiency. Review of iron preparations for practitioners. Am J Cardiovasc Drugs 2017; 17: 183–201
  13.  Ebner N, von Haehling S. Iron deficiency in heart failure: A practical guide. Nutrients 2013; 5: 3730–3739.
  14.  Macdougall IC. Clinical Kidney Journal, Volume 10, Issue suppl_1, 1. Dezember 2017, Seiten i1–i2, https://doi.org/10.1093/ckj/sfx08918
  15.  Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol. 2012;23(10):1631–4.
  16.  National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266r.
  17.  Ott C, Liebold A, Takses A, Strauch UG, Obermeier F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based. Gastroenterol Res Pract. 2012;2012:595970. doi:10.1155/2012/595970.
  18.  https://www.crohnsandcolitis.org.uk/about-inflammatory-bowel-disease. Zuletzt abgerufen: 18. September 2019.
  19.  Kappelman MD, Rifas–Shiman SL, Kleinman K, et al. The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424–1429.
  20.  Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627–40. doi:10.1016/S0140–6736(07)60750–8.
  21.  Fadi G Mirza, Rezan Abdul Kadir, Christian Breymann, Ian S Fraser & Ali Taher. Impact and management of iron deficiency and iron deficiency anemia in women’s health
  22.  Percy L, Mansour D, Fraser I. Iron deficiency and iron deficiency anaemia in women. Best Pract Res Clin Obstet Gynaecol. 2017;40:55-67.
  23.  WHO Action framework to advance universal access to safe, effective and quality assured blood products 2020–2023. Weltgesundheitsorganisation. https://www.who.int/news-room/detail/19-02-2020-who-action-framework-to-advanceuniversal-access-to-safe-effective-and-quality-assured-blood-products-2020–2023
  24.  Shander, A. et al. (2020) The Essential Role of Patient Blood Management in a Pandemic – a Call for Action. Anesthesia&Analgesia, doi: 10.1213/ANE.0000000000004844
  25.  Frank, S.M, Oleyar, M.J, Ness, P.M, Tobian, A.A. (2014) Reducing unnecessary preoperative blood orders and costs by implementing an updated institution-specific maximum surgical blood order schedule and a remote electronic blood release system. Anesthesiology, 21(3):501–9
  26.  Leahy, M.F. et al. (2017). Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion, 57(6):1347–1358